Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Ergonomic improvements in hair transplant surgery reduce discomfort for surgeons and may improve patient outcomes.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Overweight PCOS patients often have skin issues like acne, but all PCOS patients should get lifestyle advice.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Testosterone increases hair testosterone levels, stress raises hair cortisol, and relationship status affects hormone levels.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

STK11 gene polymorphism does not predict metformin response in PCOS.